Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


11.03.2019

3 Ann Otol Rhinol Laryngol
1 Ann Surg
4 Anticancer Res
1 BMC Cancer
1 Cancer Res
1 Dis Esophagus
7 Head Neck
2 Histopathology
2 Hum Pathol
4 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 Laryngoscope
11 Oral Oncol
1 Otolaryngol Head Neck Surg
4 PLoS One
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Otol Rhinol Laryngol

  1. MOSS WJ, Qualliotine JR, Finegersh A, Brumund KT, et al
    Facial Paralysis Following Core Needle Biopsy of a Deep Lobe Parotid Tumor: A Case Report.
    Ann Otol Rhinol Laryngol. 2019;128:357-359.
    PubMed     Text format     Abstract available

  2. LAZIO MS, Vallin A, Giannini C, Taverna C, et al
    Phonosurgical Resection Using Submucosal Infusion Technique for Early Glottic Lesions: Diagnostic and Therapeutic Procedure?
    Ann Otol Rhinol Laryngol. 2019;128:277-285.
    PubMed     Text format     Abstract available

  3. FENG JW, Yang XH, Wu BQ, Sun DL, et al
    Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
    Ann Otol Rhinol Laryngol. 2019 Mar 6:3489419834314.
    PubMed     Text format     Abstract available


    Ann Surg

  4. HASHIMOTO T, Makino T, Yamasaki M, Tanaka K, et al
    The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical Significance.
    Ann Surg. 2019 Jan 7. doi: 10.1097/SLA.0000000000003129.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. SPARTALIS E, Athanasiadis DI, Chrysikos D, Spartalis M, et al
    Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2019;39:1119-1127.
    PubMed     Text format     Abstract available

  6. NAKAMURA H, Tamaki S, Yagyuu T, Yamakawa N, et al
    Relationship Between EGFR Expression in Oral Cancer Cell Lines and Cetuximab Antibody-dependent Cell-mediated Cytotoxicity.
    Anticancer Res. 2019;39:1275-1282.
    PubMed     Text format     Abstract available

  7. NOZATO T, Koizumi T, Hayashi Y, Iida M, et al
    Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases.
    Anticancer Res. 2019;39:1365-1373.
    PubMed     Text format     Abstract available

  8. HAMAI Y, Emi M, Ibuki Y, Murakami Y, et al
    Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1433-1440.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. HAYASHI Y, Iijima H, Isohashi F, Tsujii Y, et al
    The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study.
    BMC Cancer. 2019;19:195.
    PubMed     Text format     Abstract available


    Cancer Res

  10. KAAKOUSH NO
    Microbiome and Esophageal Adenocarcinoma-Letter.
    Cancer Res. 2018;78:1574.
    PubMed     Text format    


    Dis Esophagus

  11. DENG HY, Zheng X, Zha P, Liang H, et al
    Can we perform esophagectomy for esophageal cancer patients with concomitant liver cirrhosis? A comprehensive systematic review and meta-analysis.
    Dis Esophagus. 2019 Mar 4. pii: 5369049. doi: 10.1093.
    PubMed     Text format     Abstract available


    Head Neck

  12. VAN SCHAIK JE, Muller Kobold AC, van der Laan BFAM, van der Vegt B, et al
    Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25733.
    PubMed     Text format     Abstract available

  13. FADEN DL, Concha-Benavente F, Chakka AB, McMichael EL, et al
    Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25726.
    PubMed     Text format     Abstract available

  14. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25727.
    PubMed     Text format     Abstract available

  15. MOHAMED A, Twardy B, Zordok MA, Ashraf K, et al
    Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25379.
    PubMed     Text format     Abstract available

  16. YASUMATSU R, Wakasaki T, Hashimoto K, Nakashima K, et al
    Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25737.
    PubMed     Text format     Abstract available

  17. BAI S, Zhang P, Zhang JC, Shen J, et al
    A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 6. doi: 10.1002/hed.25731.
    PubMed     Text format     Abstract available

  18. JANG JY, Kim DS, Park HY, Shin SC, et al
    Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
    Head Neck. 2019 Mar 7. doi: 10.1002/hed.25729.
    PubMed     Text format     Abstract available


    Histopathology

  19. SASAKI E, Nishikawa D, Hanai N, Hasegawa Y, et al
    Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion.
    Histopathology. 2018;73:953-962.
    PubMed     Text format     Abstract available

  20. URANO M, Hirai H, Tada Y, Kawakita D, et al
    The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
    Histopathology. 2018;73:943-952.
    PubMed     Text format     Abstract available


    Hum Pathol

  21. LLOYD RV, Asa SL, LiVolsi VA, Sadow PM, et al
    The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Hum Pathol. 2018;74:1-4.
    PubMed     Text format    

  22. VOLPI CC, Ciniselli CM, Gualeni AV, Plebani M, et al
    In situ hybridization detection methods for HPV16 E6/E7 mRNA in identifying transcriptionally active HPV infection of oropharyngeal carcinoma: an updating.
    Hum Pathol. 2018;74:32-42.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. CIRELLO V, Colombo C, Persani L, Fugazzola L, et al
    Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32244.
    PubMed     Text format    

  24. YE F, Gao H, Xiao L, Ding H, et al
    Reply to Cirello et al. "Absence of the MAP2K5 germline variants c.G961A and c. T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families." International Journal of Cancer 2019; in press.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32243.
    PubMed     Text format    

  25. REN S, Gaykalova D, Wang J, Guo T, et al
    Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2018;143:2425-2436.
    PubMed     Text format     Abstract available

  26. KINOUCHI M, Izumi S, Nakashiro KI, Haruyama Y, et al
    Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?
    Int J Cancer. 2018;143:2551-2560.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  27. BOSSI P, Miceli R, Granata R, Naimo S, et al
    Failure of Further Validation for Survival Nomograms in Oropharyngeal Cancer: Issues and Challenges.
    Int J Radiat Oncol Biol Phys. 2018;100:1217-1221.
    PubMed     Text format     Abstract available


    Laryngoscope

  28. YU Y, El-Sayed IH, McDermott MW, Theodosopoulos PV, et al
    Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension.
    Laryngoscope. 2018;128:2226-2233.
    PubMed     Text format     Abstract available

  29. WU MP, Sethi RKV, Emerick KS
    Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Laryngoscope. 2019 Mar 7. doi: 10.1002/lary.27881.
    PubMed     Text format     Abstract available


    Oral Oncol

  30. WANG YQ, Lv JW, Tang LL, Du XJ, et al
    Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
    Oral Oncol. 2019;90:23-29.
    PubMed     Text format     Abstract available

  31. LIU J, Zhang Z, Huang H, Xu S, et al
    Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Oral Oncol. 2019;90:17-22.
    PubMed     Text format     Abstract available

  32. GARCIA GCTE, Gorphe P, Hartl D, Ammari S, et al
    Computed tomography evaluation after induction chemotherapy for T3 laryngeal cancer: Does response correlate with vocal cord mobility?
    Oral Oncol. 2019;90:13-16.
    PubMed     Text format     Abstract available

  33. BADR H, Sobrero M, Chen J, Kotz T, et al
    Associations between pre-, post-, and peri-operative variables and health resource use following surgery for head and neck cancer.
    Oral Oncol. 2019;90:102-108.
    PubMed     Text format     Abstract available

  34. FRIEDMAN J, Padget M, Lee J, Schlom J, et al
    Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells.
    Oral Oncol. 2019;90:38-44.
    PubMed     Text format     Abstract available

  35. YUNG CS, Leung DKC, Cheung JPY
    The prevalence and impact of cervical spine pathologies in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2019;90:48-53.
    PubMed     Text format     Abstract available

  36. GUPTA A, Stokes W, Eguchi M, Hararah M, et al
    Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.
    Oral Oncol. 2019;90:54-66.
    PubMed     Text format     Abstract available

  37. KANG S
    Organ preservation in laryngeal and hypopharyngeal cancer.
    Oral Oncol. 2019;90:6-7.
    PubMed     Text format    

  38. GHANIZADA M, Jakobsen KK, Gronhoj C, von Buchwald C, et al
    The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.
    Oral Oncol. 2019;90:67-73.
    PubMed     Text format     Abstract available

  39. EL-SALEM F, Mansour M, Gitman M, Miles BA, et al
    Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostaining.
    Oral Oncol. 2019;90:74-79.
    PubMed     Text format     Abstract available

  40. DE BREE R, Takes RP, Shah JP, Hamoir M, et al
    Elective neck dissection in oral squamous cell carcinoma: Past, present and future.
    Oral Oncol. 2019;90:87-93.
    PubMed     Text format     Abstract available


    Otolaryngol Head Neck Surg

  41. HARRIS JP, Saraswathula A, Kaplun B, Qian Y, et al
    Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United States.
    Otolaryngol Head Neck Surg. 2019 Mar 5:194599819832593.
    PubMed     Text format     Abstract available


    PLoS One

  42. LOHAVANICHBUTR P, Zhang Y, Wang P, Gu H, et al
    Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
    PLoS One. 2018;13:e0204249.
    PubMed     Text format     Abstract available

  43. FACCIN TC, Cargnelutti JF, Rodrigues FS, Menezes FR, et al
    Bovine upper alimentary squamous cell carcinoma associated with bracken fern poisoning: Clinical-pathological aspects and etiopathogenesis of 100 cases.
    PLoS One. 2018;13:e0204656.
    PubMed     Text format     Abstract available

  44. FAN HC, Chen CY, Hsu YC, Chou RH, et al
    Increased risk of incident nasopharyngeal carcinoma with exposure to air pollution.
    PLoS One. 2018;13:e0204568.
    PubMed     Text format     Abstract available

  45. KYRIAKIDOU G, Friedrich-Rust M, Bon D, Sircar I, et al
    Comparison of strain elastography, point shear wave elastography using acoustic radiation force impulse imaging and 2D-shear wave elastography for the differentiation of thyroid nodules.
    PLoS One. 2018;13:e0204095.
    PubMed     Text format     Abstract available


    Radiother Oncol

  46. CAI J, Cheng J, Li H, Lin WJ, et al
    A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2019;132:34-41.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: